Abstract
Since monosodium urate (NaU) may play an important etiologic role in the formation of renal stones containing Ca in patients with hyperuricosuria, the current studies were undertaken to define some of the physiocochemical factors which determine the formation of NaU. In solutions containing Na, uric acid was rapidly transformed to NaU at pH greater than 6. The results indicated that NaU, and not uric acid, was the stable phase above this pH. A reliable and simple method for the calculation of the state of saturation of urine with respect to NaU was developed from the ratio of concentration products of Na and total dissolved urate (Upi) in the ambient fluid before and after incubation of urine with synthetic NaU. The concentration product ratio closely approximated the ratio of activity products of Na+ and acid urate ion. In contrast, the relative saturation ratio, or the ratio of activity product of original sample and the thermodynamic solubility product of NaU, often differed from the activity product ratio in the individual urine samples. With the concentration product rate, it was found in 45 urine samples that a critical determinant for the supersaturated state with respect to NaU was the high concentration of UT. At UT greater than 300 mg/liter, urine samples were invariably supersaturated with respect to NaU. These results suggest that the nidus of NaU could potentially form in the urine of patients with hyperuricosuria and Ca stones.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Coe F. L., Kavalach A. G. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19;291(25):1344–1350. doi: 10.1056/NEJM197412192912510. [DOI] [PubMed] [Google Scholar]
- Coe F. L., Lawton R. L., Goldstein R. B., Tembe V. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med. 1975 Sep;149(4):926–929. doi: 10.3181/00379727-149-38928. [DOI] [PubMed] [Google Scholar]
- Coe F. L., Raisen L. Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1973 Jan 20;1(7795):129–131. doi: 10.1016/s0140-6736(73)90197-9. [DOI] [PubMed] [Google Scholar]
- LIDDLE L., SEEGMILLER J. E., LASTER L. The enzymatic spectrophotometric method for determination of uric acid. J Lab Clin Med. 1959 Dec;54:903–913. [PubMed] [Google Scholar]
- Pak C. Y., Arnold L. H. Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med. 1975 Sep;149(4):930–932. doi: 10.3181/00379727-149-38929. [DOI] [PubMed] [Google Scholar]
- Pak C. Y., Hayashi Y., Arnold L. H. Heterogeneous nucleation with urate, calcium phosphate and calcium oxalate. Proc Soc Exp Biol Med. 1976 Oct;153(1):83–87. doi: 10.3181/00379727-153-39485. [DOI] [PubMed] [Google Scholar]
- Pak C. Y. Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite. J Clin Invest. 1969 Oct;48(10):1914–1922. doi: 10.1172/JCI106158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robertson W. G., Peacock M., Nordin B. E. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clin Sci. 1971 May;40(5):365–374. doi: 10.1042/cs0400365. [DOI] [PubMed] [Google Scholar]
- Wilcox W. R., Khalaf A., Weinberger A., Kippen I., Klinenberg J. R. Solubility of uric acid and monosodium urate. Med Biol Eng. 1972 Jul;10(4):522–531. doi: 10.1007/BF02474201. [DOI] [PubMed] [Google Scholar]